RET codon 609 mutations: A contribution for better clinical managing

Clinics

Volumn 67, Issue SUPPLEMENT, 2012, Pages 33-36

  Mian, Caterina ^a   Sartorato, Paola ^b   Barollo, Susi ^a   Zane, Mariangela ^b   Opocher, Giuseppe ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Hereditary Thyroid Cancer; Medullary Thyroid Carcinoma; MEN2A; Pheochromocytoma

Indexed keywords

CYSTEINE; PROTEIN RET; RET PROTEIN, HUMAN; SERINE;

CODON; GENETIC ASSOCIATION; GENETICS; HUMAN; HYPERPARATHYROIDISM; ITALY; MEDULLARY CARCINOMA; MUTATION; PEDIGREE; REVIEW; SIPPLE SYNDROME; THYROID TUMOR;

CARCINOMA, MEDULLARY; CODON; CYSTEINE; GENETIC ASSOCIATION STUDIES; GERM-LINE MUTATION; HUMANS; HYPERPARATHYROIDISM; ITALY; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PEDIGREE; PROTO-ONCOGENE PROTEINS C-RET; SERINE; THYROID NEOPLASMS;

EID: 84863920695     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(Sup01)07     Document Type: Review

References (14)

1. Pacini F, Castagna MG, Cipri C, Schlumberger M. Medullary thyroid carcinoma. Clin Oncol. 2010;22(6):475-85, http://dx.doi.org/10.1016/j.clon.2010.05.002.
2. Machens A, Dralle H. Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma. World J Surg. 2007;31(5):957-68, http://dx.doi.org/10.1007/s00268-006-0769-y.
3. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86(12):5658-71, http://dx.doi.org/10.1210/jc.86.12.5658.
4. Machens A, Dralle H. Familial prevalence and age of RET germline mutations: implications for screening. Clin Endocrinol. 2008;69(1):81-7, http://dx.doi.org/10.1111/j.1365-2265.2007.03153.x.
5. Simon S, Pavel M, Hensen J, Berg J, Hümmer HP, Carbon R. Multiple endocrine neoplasia 2A syndrome: surgical management. J Pediatr Surg. 2002;37(6):897-900, http://dx.doi.org/10.1053/jpsu.2002.32906.
6. Machens A, Ukkat J, Brauckhoff M, Gimm O, Dralle H. Advances in the management of hereditary medullary thyroid cancer. J Intern Med. 2005;257(1):50-9, http://dx.doi.org/10.1111/j.1365-2796.2004.01423.x.
7. Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, et al. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Clin Endocrinol. 2005;63(6):676-82, http://dx.doi.org/10.1111/j.1365-2265.2005.02400.x.
8. Calva D, O'Dorisio TM, Sue O'Dorisio M, Lal G, Sugg S, Weigel RJ, et al. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation? Ann Surg Oncol. 2009;16(8):2237-44, http://dx.doi.org/10.1245/s10434-009-0524-3.
9. Mian C, Barollo S, Zambonin L, Pennelli G, Bernante P, Pelizzo MR, et al. Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation. Fam Cancer. 2009;8(4):379-82, http://dx.doi.org/10.1007/s10689-009-9250-z.
10. Frank-Raue K, Rybicki LA, Erlic Z, Schweizer H, Winter A, Milos I, et al. International RET Exon 10 Consortium. Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat. 2011;32(1):51-8, http://dx.doi.org/10.1002/humu.21385.
11. Marsh DJ, Andrew SD, Eng C, Learoyd DL, Capes AG, Pojer R, et al. Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma. Cancer Res. 1996;56(6):1241-3.
12. Igaz P, Patócs A, Rácz K, Klein I, Váradi A, Esik O. Occurrence of pheochromocytoma in a MEN2A family with codon 609 mutation of the RET proto-oncogene. J Clin Endocrinol Metab. 2002;87(6):2994, http://dx.doi.org/10.1210/jc.87.6.2994-a.
13. Iwashita T, Kato M, Murakami H, Asai N, Ishiguro Y, Ito S, et al. Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma. Oncogene. 1999;18(26):3919-22, http://dx.doi.org/10.1038/sj.onc.1202742.
14. Fattoruso O, Quadro L, Libroia A, Verga U, Lupoli G, Cascone E, et al. A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma. Hum Mutat. 1998;11(Suppl 1):S167-71, http://dx.doi.org/10.1002/humu.1380110156.